Bridging the Gap: Conference Workbook [International Conference on AIDS (12th: 1994: Geneva, Switzerland)]

Wednesday, July 1

PSTE SESIN Trc C U37-395

33170 The thiocarboxanilide UC-781 is a potential virucidal drug
Jan Balzarini*;E. Verbeken; M. Laga;L. Van Damme; L. Van Mellaert;
J. Ann&; E. De Clerq, Belgium
33171 Tolerability of antiretroviral agents used by health-care workers (HCWs)
as postexposure prophylaxis (PEP) for occupational exposures to HIV
Adelisa Panlilio* D.M. Cardo; S. Campbell; P Srivastava;
Nash Surveillance Group, USA
33172 Post-exposure prevention (PEP) following high risk sexual
or injection drug use: A model feasibility program
James O. Kahn, USA
33173 Characteristics of individuals presenting for post-exposure prophylaxis
(PEP) following high risk sexual exposure: Opportunities for counselling
Jeffrey N. Martin*; M.E. Roland; J.O. Kahn; J. Bamberger; M.H. Katz;
M.A. Chesney; TJ. Coates, USA
33174 Post Sexual Exposure Prophylaxis (PSEP) with HAART after sexual
assault
George Opio*; R. Torres; R. Alvalle, USA
33175 Combination post-exposure prophylaxis (PEP):A prospective study of
HIV-exposed health care workers (HCW)
Julie L. Gerberding*; Rita Fahrner; S.E. Beekman; L. Nelson; J.L. Perlman;
D.K. Henderson; J.L. Gerberding, USA
33176 Post-exposure prophylaxis for occupational and sexual exposures
to HIV: experience in a London Hospital
Phillippa Easterbrook*; D. Hawkins; F Boag; A. Pearce; H. Vaile;
C. Richardson, UK
33177 Follow up of Health Care Workers (HCWs) and Prophylaxis
After an Occupational Exposure to HIV: A No Show
Pierre Robillard*; E. Roy; M. Pineault, Canada
33178 Antiretroviral prophylaxis of occupationally exposed health
care workers at two large urban medical centers
Mark Russi*; Martha Buitrago;J. Perlotto; D. Van Rhijn; E. Nash;
G. Friedland; M. Rigsby; W. Hierholzer, USA
33179 Post exposure prophylaxis: Community controversies in San Francisco
Valerie Rose Kegebein*; J.D. Bamberger; M.H. Katz; TJ. Coates, USA
33180 Risk behaviours reported by newly infected men who have sex with men
(MSM): Implication for prevention intervention
Susan Buchbinder*; D. Donnell; S. Self; K. Mayer; M. Gross;
M. Marmor; C. Celum, USA
33181 Efficacy of an out-of-house post-exposure prophylaxis team
for occupational exposures to blood-borne pathogens
Michael Wong*; RM. Allen; J. Kaatz; C. Weir-Wiggins;J. Zeh;
Fl. Tortotrella, USA
33182 Zidovudine and combination antiretroviral post exposure prophylaxis
Vincenzo Puro*; Ippolito Giuseppe; Regisco Italiano Profilassi
Antiretrovirale, Italy
33183 Potential public health impact of offering post-exposure prophylaxis
(PEP) for episodic high-risk sexual behaviour by men who have sex
with men (MSM)
Grant Colfax*; E. Vittinghoff; K. MacQueen; I. Douglas; D. McKirnan;
F. Judson; S. Buchbinder, USA

33184 Post-exposure prophylaxis for sexual risks: Implications for behavioural
prevention interventions
Seth Kalichman, USA

33185 National Clinicians' Post-Exposure Prophylaxis Hotline (PEPLine)
Julie L. Gerberding*; Jennifer L. Perlman; C Gruta; R. Fahrner;
P Liljestrand; R. Goldschmidt; J.L. Gerberding, USA
33186 Feasibility of Post-Exposure Prevention reseach among women at
HIV risk through heterosexual exposure
Richard Novak*; J. David McKirnan; Carrol Smith; David Metzer;
Pamela Brown Peter; Kenneth Mayer; Michael Marmor, USA
33187 Implementation of a surveillance and prevention program for blood
and body fluid occupational exposure in Rio de Janeiro city
Cristiane S. Rapparini*; S.C. Cavalcante; B. Durovni; W Toschi;
A.F Fonseca, Brazil
33188 Post HIV exposure prophylaxis:Who may benefit?
Philippe Sudre*; G. Schockmel; C. Fagard; L. Perrin; B. Hirschell,
Switzerland
33189 Post-exposure prophylaxis and sexual HIV transmission
between husband and wife
L.U.C Perrin*; Jean-Francois Balavoine; G.A. Schockmel;
L. Kaiser; S. Yerly; B. Hirschel; L. Perrin, Switzerland
33190 Sharps injuries and HIV: Experience with a rapid response system
Irving Salit*; Chantler;A. Tseng; J. Conly; S. Walmsley; D. Fletcher, Canada
33191 Pharmaceutical costs associated with managing a population-based HIV
accidental exposure program
Alaistair McLeod*; M. V O'Shaughnessy; B. Yip; N. Gataric; R.S. Hogg;
J.S.G. Montaner; M.T Schechter, Canada
33192 French physician's experiences and attitudes about non occupational
Post Exposure Prophylaxis (PEP)
Anne Laporte*; F Lamontagne; J. Saint-Maurice; F Lot, France
33193 Oral chemoprophylaxis to prevent HIV-infection: Attitudes and interest
among high risk HIV-negative US populations
Michael Gross*; S. Holte; S.R Buchbinder; K.H. Mayer; D.S. Metzger;
G.R. Seage, USA
33194 Occupational risk for HIV-infection and postexposure chemoprophylaxis
in a hospital for infectious diseases
Elisabeta Otilia Benea*;S. Petrea; G. Coltan, Romania
33195 Assistance to health care workers exposed to HIV in an university
hospital in Southeastern Brazil
Carlos Magno C. Fort Aleza*; Francisco Hideo Aoki; C.M.C. Fortaleza;
M.R. Resende; R.M. Figueiredo; M. T Garcia; PM.O. Papaiordanou, Brazil
NOTES

CONFERENCE WORKBOOK

153